This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Adverse reactions of meningococcal vaccination

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

MenC conjugate vaccine

  • pain, tenderness, swelling, or redness at the injection site and mild fevers are common in all age groups
  • in infants and toddlers
    • crying, irritability, drowsiness, impaired sleep, reduced eating, diarrhoea and vomiting are commonly seen
  • in older children and adults, headaches, myalgia and drowsiness may be seen
  • confirmed anaphylaxis after immunisation is extremely rare
  • neurological reactions such as dizziness, febrile/afebrile seizures, faints, numbness and hypotonia following MenC are very rare

Hib/MenC conjugate

  • mild side effects such as irritability, loss of appetite, pain, swelling, redness at the site of the injection and slightly raised temperature commonly occur
  • Less commonly crying, diarrhoea, vomiting, atopic dermatitis, malaise and fever over 39.5°C have been reported

Meningococcal quadrivalent (ACWY) polysaccharide vaccine

  • for Menveo
    • very common or common reported reactions included injection site reactions including pain, erythema, induration and pruritus
    • other very common or common reactions include headache, nausea, rash and malaise. Reports of all adverse reactions can be found in the Summary of Product Characteristics
  • for Nimenrix
    • very common or common reported reactions included injection site reactions including pain, erythema, and swelling
    • other very common or common reactions include irritability, drowsiness, headache, nausea, and loss of appetite
    • reports of all adverse reactions can be found in the Summary of Product Characteristics for Nimenrix

4CMenB vaccine

  • for 4CMenB (BexseroR)
    • the most common local and systemic adverse reactions observed in adolescents and adults were pain at the injection site, malaise and headache
    • in infants and children up to ten years of age
      • injection site reactions, fever (>=38oC) and irritability were very commonly seen
      • diarrhoea and vomiting, eating disorders, sleepiness, unusual crying and the development of a rash were commonly or very commonly seen
      • reports of all adverse reactions can be found in the Summary of Product Characteristics for BexseroR
    • in infants and children under two years of age, fever >=38oC (occasionally >=39oC) was more common when 4CMenB was administered at the same time as routine vaccines than when 4CMenB was given alone
      • fever peaks at around 6 hours and has usually gone by 48 hours after vaccination
    • JCVI have recommended, therefore, that paracetamol should be given prophylactically when 4CMenB is given with the routine vaccines in infants under one year of age

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 16 Haemophilis influenzae type B (Hib) (April 2019)
  2. Start of the new meningococcal C conjugate vaccine immunisation programme (11/10/99)
  3. PL/CMO/99/4.PL/CNO/99/8, PL/CPHO/99/3 (2) CMO's Update 27 (August 2000), 4.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.